Reports - Genomic Biomarkers Market
HealthcareGenomic Biomarkers Market
Genomic Biomarkers Market Size, Share & Growth Forecast by 2035 by Type (Predictive Biomarkers, Prognostic Biomarkers) by Disease Indication (Oncology, Cardiovascular Diseases, Neurological Diseases, Renal Disorders, Other Disease Indications) by Validation (Analytical Validation, Clinical Validation, Clinical Utility) by End User (Hospitals, Diagnostic Centers, Research Laboratories, Other End Users) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Genomic Biomarkers Market - Segment Analysis
1. Overview
2. Global Genomic Biomarkers Market, 2021 - 2035 (USD Million)
3. Global Genomic Biomarkers Market - by Type
3.1. By Predictive Biomarkers
3.2. By Prognostic Biomarkers
4. Global Genomic Biomarkers Market - by Disease Indication
4.1. By Oncology
4.2. By Cardiovascular Diseases
4.3. By Neurological Diseases
4.4. By Renal Disorders
4.5. By Other Disease Indications
5. Global Genomic Biomarkers Market - by Validation
5.1. By Analytical Validation
5.2. By Clinical Validation
5.3. By Clinical Utility
6. Global Genomic Biomarkers Market - by End User
6.1. By Hospitals
6.2. By Diagnostic Centers
6.3. By Research Laboratories
6.4. By Other End Users
7. Global Genomic Biomarkers Market - by region
7.1. North America
7.2. Europe
7.3. Asia Pacific
7.4. Latin America
7.5. Middle East & Africa
8. Market comparative analysis
Chapter 4 North America Genomic Biomarkers Market - Segment Analysis
1. Overview
2. North America Genomic Biomarkers Market, 2021 - 2035 (USD Million)
3. North America Genomic Biomarkers Market - by Type
3.1. By Predictive Biomarkers
3.2. By Prognostic Biomarkers
4. North America Genomic Biomarkers Market - by Disease Indication
4.1. By Oncology
4.2. By Cardiovascular Diseases
4.3. By Neurological Diseases
4.4. By Renal Disorders
4.5. By Other Disease Indications
5. North America Genomic Biomarkers Market - by Validation
5.1. By Analytical Validation
5.2. By Clinical Validation
5.3. By Clinical Utility
6. North America Genomic Biomarkers Market - by End User
6.1. By Hospitals
6.2. By Diagnostic Centers
6.3. By Research Laboratories
6.4. By Other End Users
Chapter 5 Europe Genomic Biomarkers Market - Segment Analysis
1. Overview
2. Europe Genomic Biomarkers Market, 2021 - 2035 (USD Million)
3. Europe Genomic Biomarkers Market - by Type
3.1. By Predictive Biomarkers
3.2. By Prognostic Biomarkers
4. Europe Genomic Biomarkers Market - by Disease Indication
4.1. By Oncology
4.2. By Cardiovascular Diseases
4.3. By Neurological Diseases
4.4. By Renal Disorders
4.5. By Other Disease Indications
5. Europe Genomic Biomarkers Market - by Validation
5.1. By Analytical Validation
5.2. By Clinical Validation
5.3. By Clinical Utility
6. Europe Genomic Biomarkers Market - by End User
6.1. By Hospitals
6.2. By Diagnostic Centers
6.3. By Research Laboratories
6.4. By Other End Users
Chapter 6 Asia Pacific Genomic Biomarkers Market - Segment Analysis
1. Overview
2. Asia Pacific Genomic Biomarkers Market, 2021 - 2035 (USD Million)
3. Asia Pacific Genomic Biomarkers Market - by Type
3.1. By Predictive Biomarkers
3.2. By Prognostic Biomarkers
4. Asia Pacific Genomic Biomarkers Market - by Disease Indication
4.1. By Oncology
4.2. By Cardiovascular Diseases
4.3. By Neurological Diseases
4.4. By Renal Disorders
4.5. By Other Disease Indications
5. Asia Pacific Genomic Biomarkers Market - by Validation
5.1. By Analytical Validation
5.2. By Clinical Validation
5.3. By Clinical Utility
6. Asia Pacific Genomic Biomarkers Market - by End User
6.1. By Hospitals
6.2. By Diagnostic Centers
6.3. By Research Laboratories
6.4. By Other End Users
Chapter 7 Latin America Genomic Biomarkers Market - Segment Analysis
1. Overview
2. Latin America Genomic Biomarkers Market, 2021 - 2035 (USD Million)
3. Latin America Genomic Biomarkers Market - by Type
3.1. By Predictive Biomarkers
3.2. By Prognostic Biomarkers
4. Latin America Genomic Biomarkers Market - by Disease Indication
4.1. By Oncology
4.2. By Cardiovascular Diseases
4.3. By Neurological Diseases
4.4. By Renal Disorders
4.5. By Other Disease Indications
5. Latin America Genomic Biomarkers Market - by Validation
5.1. By Analytical Validation
5.2. By Clinical Validation
5.3. By Clinical Utility
6. Latin America Genomic Biomarkers Market - by End User
6.1. By Hospitals
6.2. By Diagnostic Centers
6.3. By Research Laboratories
6.4. By Other End Users
Chapter 8 Middle East & Africa Genomic Biomarkers Market - Segment Analysis
1. Overview
2. Middle East & Africa Genomic Biomarkers Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Genomic Biomarkers Market - by Type
3.1. By Predictive Biomarkers
3.2. By Prognostic Biomarkers
4. Middle East & Africa Genomic Biomarkers Market - by Disease Indication
4.1. By Oncology
4.2. By Cardiovascular Diseases
4.3. By Neurological Diseases
4.4. By Renal Disorders
4.5. By Other Disease Indications
5. Middle East & Africa Genomic Biomarkers Market - by Validation
5.1. By Analytical Validation
5.2. By Clinical Validation
5.3. By Clinical Utility
6. Middle East & Africa Genomic Biomarkers Market - by End User
6.1. By Hospitals
6.2. By Diagnostic Centers
6.3. By Research Laboratories
6.4. By Other End Users
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. Thermo Fisher Scientific Inc. (U.S.)
2. F. Hoffmann-La Roche AG (Switzerland)
3. QIAGEN (Germany)
4. Bio-Rad Laboratories Inc. (U.S.)
5. Myriad Genetics Inc. (U.S.)
6. Eurofins Scientific (Luxembourg)
7. Almac Group (UK)
8. Agilent (U.S.)
9. Illumina (U.S.)
10. Pfizer Inc. (U.S.)
11. Danaher Corp. (U.S.)
12. Siemens Healthineers AG (Germany)
13. Merck KGaA (Germany)
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By